Dutch See First European Launch Of Clinuvel's Scenesse For Phototoxicity In EPP
Executive Summary
Clinuvel is beginning the commercial launch in Europe of its orphan drug Scenesse for patients with erythropoietic protoporphyria, a rare condition that causes severe anaphylactic reactions and burns when the skin is exposed to sunlight.